SAWAI GROUP HOLDINGS Co.,Ltd.

4887 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥1,580.50
-1.53%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Comfortable interest cover: operating profit covers interest about 9 times.
  • Net profit margin is 5.2%.
  • Current assets comfortably cover current liabilities (current ratio 18.8).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 1.02 is above 1.
  • Return on equity is on the lower side at 5.9%.
  • Return on capital employed is on the lower side at 4.6%.
  • Sales growth has been slow over five years (about 1% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
1.97

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥1,825億
Current Price¥ 1,580.50
High / Low¥ 2,447.00 / 1,550.50
Stock P/E15.873255
Book Value¥ 1,479.77
Dividend Yield3.43%
ROCE4.55%
ROE5.90%
Debt to Equity1.02
Current Ratio18.80
P/B Ratio1.0274242
EPS¥ 90.39
PAT Margin5.18%
ICR9.00
Compounded Sales Growth
10 Years
5 Years 1.00%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 5.90%
Educational data only. Not a recommendation to buy, sell or hold any security.